ArticleEuropean urology open science2026
PSA Response as a Prognostic Factor of Overall Survival in Patients with Metastatic Hormone-sensitive Prostate Cancer Treated with Apalutamide: Real-world Evidence.
Ana Guijarro et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.